Munc13-4 deficiency with CD5 downregulation on activated CD8+ T cells

Pediatrics International

Volumn 56, Issue 4, 2014, Pages 605-608

  Wada, Taizo ^a   Yasumi, Takahiro ^b   Toma, Tomoko ^a   Hori, Masayuki ^b   Maeda, Sayaka ^b   Umeda, Katsutsugu ^b   Heike, Toshio ^b   Adachi, Souichi ^b   Usami, Ikuya ^c   Yachie, Akihiro ^a  

^a Faculty of Health Sciences   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Hyogo Prefectural Tsukaguchi Hospital   (Japan)

Author keywords

CD5; CD8+ T cells; Familial hemophagocytic lymphohistiocytosis; Munc13 4; UNC13D

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CD45RO ANTIGEN; CD5 ANTIGEN; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; DEXAMETHASONE; ETOPOSIDE; GANCICLOVIR; HLA DR ANTIGEN; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 18; INTERLEUKIN 6; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NEOPTERIN; PERFORIN; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VIRUS DNA; MEMBRANE PROTEIN; UNC13D PROTEIN, HUMAN;

ANTIBODY TITER; ARTICLE; CASE REPORT; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINE STORM; CYTOMEGALOVIRUS INFECTION; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DOWN REGULATION; FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS TYPE 3; FEVER; FLOW CYTOMETRY; GENE DOSAGE; HEMOPHAGOCYTIC SYNDROME; HETEROZYGOTE; HUMAN; HUMAN CELL; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; IMMUNE DYSREGULATION; IMMUNOPHENOTYPING; INTRON; KOREAN (PEOPLE); LABORATORY TEST; LIVER; MALE; MILD HEPATIC IMPAIRMENT; MUNC 13 4 DEFICIENCY; MUTATOR GENE; NATURAL KILLER CELL; NEWBORN; PALPATION; PETECHIA; PLASMAPHERESIS; PRIORITY JOURNAL; RELEASE ASSAY; SPLEEN; SPLICING DEFECT; SYSTEMIC DISEASE; T LYMPHOCYTE ACTIVATION; UNC13D GENE; DEFICIENCY; INFANT; LYMPHOCYTE ACTIVATION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; PHYSIOLOGY;

ANTIGENS, CD5; CD8-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; HUMANS; INFANT; LYMPHOCYTE ACTIVATION; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MEMBRANE PROTEINS;

EID: 84961345212     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12290     Document Type: Article

References (10)

1. Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br. J. Haematol. 2013; 161: 609-22.
2. Nagai K, Yamamoto K, Fujiwara H et al. Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes. PLoS ONE 2010; 5: e14173.
3. Wada T, Sakakibara Y, Nishimura R et al. Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations. Hum. Immunol. 2013; 74: 1579-85.
4. Lozano F, Simarro M, Calvo J et al. CD5 signal transduction: Positive or negative modulation of antigen receptor signaling. Crit. Rev. Immunol. 2000; 20: 347-58.
5. Brossard C, Semichon M, Trautmann A., Bismuth G. CD5 inhibits signaling at the immunological synapse without impairing its formation. J. Immunol. 2003; 170: 4623-9.
6. Murata Y, Yasumi T, Shirakawa R et al. Rapid diagnosis of FHL3 by flow cytometric detection of intraplatelet Munc13-4 protein. Blood 2011; 118: 1225-30.
7. Seo JY, Song JS, Lee KO et al. Founder effects in two predominant intronic mutations of UNC13D, c.118-308C>T and c.754-1G>C underlie the unusual predominance of type 3 familial hemophagocytic lymphohistiocytosis (FHL3) in Korea. Ann. Hematol. 2013; 92: 357-64.
8. Toga A, Wada T, Sakakibara Y et al. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis. J. Infect. Dis. 2010; 201: 1923-32.
9. Tarakhovsky A, Kanner SB, Hombach J et al. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 1995; 269: 535-7.
10. Meeths M, Chiang SC, Wood SM et al. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood 2011; 118: 5783-93.